Bioinformatics Startups Hit with Cash Crunch as VCs Tighten the Purse Strings | GenomeWeb

  Anyone could tell you that this isn’t the ideal economic climate to go looking for venture capital funding, no matter what kind of business you run. But for early-stage bioinformatics companies, it seems that the going is especially rough, as the general economic slowdown has only served to drive home a situation that some say was a long time in coming: Until bioinformatics companies prove they can make money, funding will remain hard to find.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.